Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Double Blind Study Of The Safety And Pharmacokinetics Of Multiple Doses Of CE 224,535 In Subjects With Rheumatoid Arthritis Receiving Methotrexate

NCT00446784 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00446784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00446784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Double Blind Study Of The Safety And Pharmacokinetics Of Multiple Doses Of CE 224,535 In Subjects With Rheumatoid Arthritis Receiving Methotrexate
Lead sponsor
Pfizer
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2007
Completion date
August 31, 2007
Enrollment
20
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, rheumatoid